Neuroendocrine Tumors

Monday, April 29, 2019 - 10:30am
The mission of cancer research – to find better and more effective ways to treat or prevent cancer – begins with a better understanding of the disease. Knowing how a cancer begins and how it grows is an important first step toward fighting it and has led to remarkable advances in oncology.
Friday, April 5, 2019 - 10:00am
“While the side effects were very challenging for me to manage, the care I got at Roswell was unbelievable. Everybody,  from doctors and nurses to cleaning staff, made me feel so valued and cared for during that difficult time.”
Wednesday, March 21, 2018 - 8:00am
On January 29, the Food and Drug Administration approved a lutetium Lu 177 dotatate (Lutathera®), a targeted radiation drug, for the treatment of gastroenteropancreatic neuroendocrine tumors.
Friday, November 10, 2017 - 12:43pm
Neuroendocrine tumors (NETs) are called the zebra of cancers because they are rare, and behave very differently from other cancer types. While NETs are typically small and slow growing, they can develop anywhere in the body, most commonly the stomach, intestines, pancreas, lungs and liver. Since they don’t show up on typical PET scans, finding them at early stages or detecting metastasis is difficult.
Tuesday, October 24, 2017 - 8:05am
When Megan Johnson was 21 months old, a large tumor collapsed her lung and pushed her heart to the other side of her chest. It was a primitive neuroectodermal tumor (PNET), a rare and very aggressive type of cancer. Doctors advised her parents that her chances of survival were less than 10 percent.
Wednesday, July 19, 2017 - 10:02am

A new agent, gallium-68 dotatate (Netspot®), recently FDA-approved and available at Roswell Park, can be used as a PET tracer instead of the glucose to identify carcinoid tumorseven very small lesionssignificantly better than any currently available imaging.

Sunday, November 20, 2016 - 8:00am

There are certain times of year when my cancer story makes me feel incredibly isolated. There’s the time surrounding April 14, the day I was diagnosed, July 29, the day I was deemed “in remission” and, the one I’ve experienced most recently, the month of October.

Wednesday, August 19, 2015 - 11:28am
The 2015 Neuroendocrine Tumor (NET) Patient Regional Meeting is coming up on Saturday, Aug. 29. NET patients and caregivers are invited for an afternoon of networking, information sharing and support—all tailored to the unique needs of the NET patient community.
Tuesday, July 9, 2013 - 8:12am

If you heard hoofbeats, what animal would you think of? A horse, right? It’s the most obvious answer.